Bain, S., Leiter, L. A., Bain, S. C., Hramiak, I., Jódar, E., Madsbad, S., . . . Lingvay, I. (2019). Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: A post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial. Cardiovascular Diabetology, 18(1), . doi:10.1186/s12933-019-0871-8

Bain, Steve, et al. "Cardiovascular Risk Reduction With Once-weekly Semaglutide in Subjects With Type 2 Diabetes: A Post Hoc Analysis of Gender, Age, and Baseline CV Risk Profile in the SUSTAIN 6 Trial." Cardiovascular Diabetology 18, no. 1 (2019).

Bain, Steve, et al. "Cardiovascular Risk Reduction With Once-weekly Semaglutide in Subjects With Type 2 Diabetes: A Post Hoc Analysis of Gender, Age, and Baseline CV Risk Profile in the SUSTAIN 6 Trial." Cardiovascular Diabetology 18.1 (2019).